Amphastar Pharmaceuticals AMPH Income Tax Refund And Deposits
Income Tax Refund And Deposits at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept amph:IncomeTaxRefundAndDeposits.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's income tax refund and deposits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's income tax refund and deposits?
- Amphastar Pharmaceuticals (AMPH) reported income tax refund and deposits of $9.61M in Q1 2026.
- How has Amphastar Pharmaceuticals's income tax refund and deposits changed year-over-year?
- Amphastar Pharmaceuticals's income tax refund and deposits increased by 1167.2% year-over-year, from $758K to $9.61M.
- What is the long-term trend for Amphastar Pharmaceuticals's income tax refund and deposits?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's income tax refund and deposits has grown at a 113.7% compound annual growth rate (CAGR), from $385K to $17.17M.
- What does income tax refund and deposits mean?
- This metric represents the aggregate value of anticipated income tax refunds due from tax authorities and cash deposits held with government agencies. It reflects short-term liquidity tied up in tax-related receivables that are expected to be recovered or utilized within the next fiscal year. Monitoring this balance helps investors assess the efficiency of the company's tax planning and the potential for near-term cash inflows from tax settlements.